BN 50341

BN 50341 is an orally active anticalcic agent and a benzazepine derivative. BN 50341 decreases the in vivo electrically induced thrombus formation in rat or guinea-pig artery and can be utilized in cardiovascular research[1].

Product Specifications

CAS Number

[107550-66-3]

UNSPSC

12352005

Target

Others

Type

Reference compound

Related Pathways

Others

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/bn-50341.html

Smiles

COC1=CC(CCN(CCCN2C=CC3=C(C(C2)C4=CC=CC=C4)C=C(OC)C(OC)=C3)C)=CC=C1OC.Cl

Molecular Formula

C32H41ClN2O4

Molecular Weight

553.13

References & Citations

[1]Etienne A, et al. Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. Agents Actions Suppl. 1986;20:259-66.